Table 1.
Patient no. | Sex | Tested negative | Age (years) |
Location of primary | Hypersecretion | Time to metastasis (years) | Location of metastases | |
---|---|---|---|---|---|---|---|---|
Diagnosis | Time of study | |||||||
1 | m | SDHx, VHL | 61 | 75 | Right adrenal | NM, NE, DA, CgA | 12 | A/P |
2 | f | SDHx | 52 | 55 | Left adrenal | NM, NE, CgA | 3 | A/P, B |
3 | f | SDHx | 54 | 54 | Left para-adrenal | NM, NE, CgA | 0 | A/P, B |
4 | m | SDHx, MEN, VHL, TMEM 127 | 20 | 37 | Right para-adrenal | NM | 0 | A/P, B, Li, Lu |
5 | m | SDHx, MEN, VHL | 27 | 30 | Unknown | NE, NM, DA, CgA | 0 | A/P, B, Li, Me |
6 | f | SDHx | 21 | 46 | Right glomus jugulare | None | 9 | A/P, B, Me, Ne |
7 | f | SDHx, MEN, VHL, MAX, TMEM 127 | 52 | 64 | Left adrenal | NM, NE, DA, MTT, CgA | 6 | A/P, B, Li, Lu |
8 | f | SDHx, MAX | 38 | 47 | Left adrenal | NM, MN, CgA | 7 | B |
9 | f | SDHx | 12 | 31 | Left para-adrenal | CgA, | 4 | A/P, B, Lu |
10 | m | SDHx | 56 | 59 | Right adrenal | NM, MN, NE, DA, CgA | 0 | A/P, B, Lu, Ne |
11 | m | SDHx | 42 | 52 | Unknown | DA, CgA, MTT | 5 | A/P, B, Lu, Me, Ne |
12 | m | SDHx | 49 | 52 | Right retroperitoneal | CgA | 0 | B, Li |
13 | m | SDHx, VHL | 54 | 61 | Left adrenal | NM, NE, CgA, DA | 0 | A/P, B, Li, Lu, Me |
14 | m | SDHx, MAX | 70 | 73 | Left adrenal | NM, NE, CgA, DA | 0 | A/P, Lu, Me |
15 | m | SDHx | 34 | 35 | Left retroperitoneal | NM, NE, MN, Epi, DA, CgA | 0 | A/P, B, Li, Lu |
16 | m | SDHx | 31 | 43 | Right adrenal | NM, NE, DA, CgA | 6 | A/P, B, Me |
17 | m | SDHx, VHL | 23 | 25 | Right adrenal | NM, NE, DA, CgA, MTT | 0 | A/P, B, Li, Lu |
18 | m | SDHx | 38 | 39 | Right para-adrenal | NM, CgA | 0 | A/P, B, Li, Me |
19 | m | SDHx | 43 | 64 | Right adrenal | NM, NE, MN, Epi, DA, CgA, MTT | 15 | A/P, B |
20 | m | SDHx | 34 | 41 | Left adrenal | MTT | 5 | A/P, B |
21 | f | SDHx | 63 | 64 | Left adrenal | NM, NE, Epi, CgA, MTT | 0 | B, Li |
22 | m | SDHx | 37 | 39 | Right adrenal | NM, DA | 2 | B, Li, Lu |
A/P abdominal/pelvic compartment, B bones, CgA chromogranin A, DA dopamine, Epi epinephrine, Li liver, Lu lungs, m male, MAX myc-associated factor X, Me mediastinum, MTT methoxytyramine, Ne neck, NE norepinephrine, NM normetanephrine, TMEM 127 trans-membrane protein 127